176 related articles for article (PubMed ID: 23084584)
61. Intestinal and pancreatic metaplasia at the esophagogastric junction in patients without Barrett's esophagus.
Polkowski W; van Lanschot JJ; ten Kate FJ; Rolf TM; Polak M; Tytgat GN; Obertop H; Offerhaus GJ
Am J Gastroenterol; 2000 Mar; 95(3):617-25. PubMed ID: 10710048
[TBL] [Abstract][Full Text] [Related]
62. Esophageal pepsin and proton pump synthesis in barrett's esophagus and esophageal adenocarcinoma.
Samuels TL; Altman KW; Gould JC; Kindel T; Bosler M; MacKinnon A; Hagen CE; Johnston N
Laryngoscope; 2019 Dec; 129(12):2687-2695. PubMed ID: 31046139
[TBL] [Abstract][Full Text] [Related]
63. [Expression of Cdx-2 homeobox gene in intestinal metaplasia and gastric adenocarcinoma].
Paik CH; Han DS; Lee SH; Chung YW; Kim JP; Sohn JH; Hahm JS; Oh YH; Park YU
Korean J Gastroenterol; 2004 Oct; 44(4):186-92. PubMed ID: 15505429
[TBL] [Abstract][Full Text] [Related]
64. Overexpression of the p53 tumor suppressor gene product in esophageal and gastric carcinomas.
Fléjou JF; Muzeau F; Potet F; Lepelletier F; Fékété F; Hénin D
Pathol Res Pract; 1994 Dec; 190(12):1141-8. PubMed ID: 7540752
[TBL] [Abstract][Full Text] [Related]
65. Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus.
Zou H; Molina JR; Harrington JJ; Osborn NK; Klatt KK; Romero Y; Burgart LJ; Ahlquist DA
Int J Cancer; 2005 Sep; 116(4):584-91. PubMed ID: 15825175
[TBL] [Abstract][Full Text] [Related]
66. Blood-group phenotypes, sulfomucins, and Helicobacter pylori in Barrett's esophagus.
Torrado J; Ruiz B; Garay J; Asenjo JL; Tovar JA; Cosme A; Correa P
Am J Surg Pathol; 1997 Sep; 21(9):1023-9. PubMed ID: 9298878
[TBL] [Abstract][Full Text] [Related]
67. Prognostic value of Laurén classification and c-erbB-2 oncogene overexpression in adenocarcinoma of the esophagus and gastroesophageal junction.
Polkowski W; van Sandick JW; Offerhaus GJ; ten Kate FJ; Mulder J; Obertop H; van Lanschot JJ
Ann Surg Oncol; 1999; 6(3):290-7. PubMed ID: 10340889
[TBL] [Abstract][Full Text] [Related]
68. LI-cadherin: a marker of gastric metaplasia and neoplasia.
Grötzinger C; Kneifel J; Patschan D; Schnoy N; Anagnostopoulos I; Faiss S; Tauber R; Wiedenmann B; Gessner R
Gut; 2001 Jul; 49(1):73-81. PubMed ID: 11413113
[TBL] [Abstract][Full Text] [Related]
69. Expression of apoptosis-related proteins in Barrett's metaplasia-dysplasia-carcinoma sequence: a switch to a more resistant phenotype.
van der Woude CJ; Jansen PL; Tiebosch AT; Beuving A; Homan M; Kleibeuker JH; Moshage H
Hum Pathol; 2002 Jul; 33(7):686-92. PubMed ID: 12196918
[TBL] [Abstract][Full Text] [Related]
70. Clinicopathological study of early adenocarcinoma of the gastric cardia: comparison with early adenocarcinoma of the distal stomach and esophagus.
Tajima Y; Nakanishi Y; Yoshino T; Kokawa A; Kusano M; Shimoda T
Oncology; 2001; 61(1):1-9. PubMed ID: 11474241
[TBL] [Abstract][Full Text] [Related]
71. Intestinal differentiation and p53 gene alterations in Barrett's esophagus and esophageal adenocarcinoma.
Moore JH; Lesser EJ; Erdody DH; Natale RB; Orringer MB; Beer DG
Int J Cancer; 1994 Feb; 56(4):487-93. PubMed ID: 7906678
[TBL] [Abstract][Full Text] [Related]
72. Cdx2 Animal Models Reveal Developmental Origins of Cancers.
Chawengsaksophak K
Genes (Basel); 2019 Nov; 10(11):. PubMed ID: 31739541
[TBL] [Abstract][Full Text] [Related]
73. Expression and Prognostic Significance of Human Epidermal Growth Factor Receptors 1 and 3 in Gastric and Esophageal Adenocarcinoma.
Hedner C; Borg D; Nodin B; Karnevi E; Jirström K; Eberhard J
PLoS One; 2016; 11(2):e0148101. PubMed ID: 26844548
[TBL] [Abstract][Full Text] [Related]
74. Downregulation of Notch Signaling in Kras-Induced Gastric Metaplasia.
Chung WC; Zhou Y; Atfi A; Xu K
Neoplasia; 2019 Aug; 21(8):810-821. PubMed ID: 31276933
[TBL] [Abstract][Full Text] [Related]
75. Claudin expression in gastric adenocarcinomas: a tissue microarray study with prognostic correlation.
Resnick MB; Gavilanez M; Newton E; Konkin T; Bhattacharya B; Britt DE; Sabo E; Moss SF
Hum Pathol; 2005 Aug; 36(8):886-92. PubMed ID: 16112005
[TBL] [Abstract][Full Text] [Related]
76. Adenocarcinoma of the upper esophagus arising in heterotopic gastric mucosa: common pathogenesis with Barrett's adenocarcinoma?
Chatelain D; de Lajarte-Thirouard AS; Tiret E; Flejou JF
Virchows Arch; 2002 Oct; 441(4):406-11. PubMed ID: 12516606
[TBL] [Abstract][Full Text] [Related]
77. Molecular Evolution of Metaplasia to Adenocarcinoma in the Esophagus.
Grady WM; Yu M
Dig Dis Sci; 2018 Aug; 63(8):2059-2069. PubMed ID: 29766388
[TBL] [Abstract][Full Text] [Related]
78. Involvement of cancer-activating genes on chromosomes 7 and 8 in esophageal (Barrett's) and gastric cardia adenocarcinoma.
Vissers KJ; Riegman PH; Alers JC; Tilanus HW; van Dekken H
Anticancer Res; 2001; 21(6A):3813-20. PubMed ID: 11911252
[TBL] [Abstract][Full Text] [Related]
79. Chromosomal numerical aberrations are frequent in oesophageal and gastric adenocarcinomas: a study using in-situ hybridization.
Beuzen F; Dubois S; Fléjou JF
Histopathology; 2000 Sep; 37(3):241-9. PubMed ID: 10971700
[TBL] [Abstract][Full Text] [Related]
80. Dynamics of SOX2 and CDX2 Expression in Barrett's Mucosa.
Barros R; Pereira D; Callé C; Camilo V; Cunha AI; David L; Almeida R; Dias-Pereira A; Chaves P
Dis Markers; 2016; 2016():1532791. PubMed ID: 27766003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
